{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:19:04Z","timestamp":1777115944988,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1124\/dmd.108.022285","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:59:11Z","timestamp":1219971551000},"page":"2492-2498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Involvement of Intestinal Uptake Transporters in the Absorption of Azithromycin and Clarithromycin in the Rat"],"prefix":"10.1016","volume":"36","author":[{"given":"Eric","family":"Garver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin D.","family":"Hugger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn P.","family":"Shearn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.022285_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.clpt.6100104","article-title":"Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice","volume":"81","author":"Bailey","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.108.022285_bib2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1124\/dmd.31.11.1337","article-title":"Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroids plexus of rats","volume":"31","author":"Choudhuri","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.022285_bib3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0090-9556(24)15235-X","article-title":"OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine","volume":"27","author":"Cvetkovic","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.022285_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/jhep.2000.8539","article-title":"Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides Oatp1 and Oatp2","volume":"32","author":"Fattinger","year":"2000","journal-title":"Hepatology"},{"issue":"Suppl A","key":"10.1124\/dmd.108.022285_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.108.022285_bib6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hep.510240407","article-title":"Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin","volume":"24","author":"Fromm","year":"1996","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1124\/dmd.108.022285_bib7","first-page":"245","article-title":"Organic anion transporter polypeptide (OATP) mediates oral absorption of azithromycin in the rat. ISSX Poster. Abstract published","volume":"38","author":"Garver","year":"2006","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.108.022285_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.clpt.6100056","article-title":"Intestinal drug transporter expression and the impact of grapefruit juice in humans","volume":"81","author":"Glaeser","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.108.022285_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","article-title":"The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin","volume":"104","author":"Greiner","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.108.022285_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.108.022285_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mcp.2001.113697","article-title":"The effect of rifampin administration on the disposition of fexofenadine","volume":"69","author":"Hamman","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.108.022285_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2133\/dmpk.21.308","article-title":"Transporter-mediated intestinal absorption of fexofenadine in rats","volume":"21","author":"Kikuchi","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"issue":"Suppl 2","key":"10.1124\/dmd.108.022285_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2362.33.s2.5.x","article-title":"Organic anion-transporting polypeptide (OATP) transporter family and drug disposition","volume":"33","author":"Kim","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/dmd.108.022285_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1124\/dmd.106.009258","article-title":"In vitro and in vivo correlation of hepatic transporter effects of erythromycin metabolism: characterizing the importance of transporter-enzyme interplay","volume":"34","author":"Lam","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.022285_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.108.022285_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/phgs.5.3.273.29831","article-title":"Pharmacogenomics of the OATP and OAT families","volume":"5","author":"Marzolini","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.108.022285_bib17","first-page":"1","article-title":"Experimental estimation of the role of P-glycoprotein in the pharmacokinetic behavior of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model","volume":"6","author":"Pachot","year":"2003","journal-title":"J Pharm Pharm Sci"},{"key":"10.1124\/dmd.108.022285_bib18","first-page":"74","article-title":"New strategies to address drug-drug interactions involving OATPs","volume":"10","author":"Poirier","year":"2007","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1124\/dmd.108.022285_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/dmd.106.014407","article-title":"The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3","volume":"35","author":"Seithel","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"Suppl A","key":"10.1124\/dmd.108.022285_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/25.suppl_A.49","article-title":"Pharmacokinetics of azithromycin in rats and dogs","volume":"25","author":"Shepard","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.108.022285_bib21","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/dmd.105.004622","article-title":"Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans","volume":"33","author":"Shimizu","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.022285_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1128\/AAC.48.3.809-814.2004","article-title":"Possible involvement of the drug transporters P glycoprotein and multi-drug resistance-associated protein Mrp2 in disposition of azithromycin","volume":"48","author":"Sugie","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.108.022285_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/bbrc.2000.2922","article-title":"Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family","volume":"273","author":"Tamai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.108.022285_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0009-9236(03)00238-8","article-title":"Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine","volume":"74","author":"Tannergren","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.108.022285_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2002.34133","article-title":"Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver","volume":"36","author":"Vavricka","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/dmd.108.022285_bib26","doi-asserted-by":"crossref","first-page":"G1188","DOI":"10.1152\/ajpgi.2000.279.6.G1188","article-title":"Expression, transport properties, and chromosomal location of organic anion transporter subtype 3","volume":"279","author":"Walters","year":"2000","journal-title":"Am J Gastrointest Liver Physiol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624018786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624018786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.022285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:32:00Z","timestamp":1739896320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624018786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0090955624018786"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.022285","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of Intestinal Uptake Transporters in the Absorption of Azithromycin and Clarithromycin in the Rat","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.022285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}